Sarcopenia and Mortality in Critically Ill COVID-19 Patients
COVID-19 can manifest as either asymptomatic or progressing to a severe phase in some patients, which may require hospitalization. These patients may experience dyspnea and hypoxia, leading to the development of acute respiratory distress syndrome. Studies have reported an increased risk of severe s...
Main Authors: | Fatima Al Zahra Yakti, Lana Abusalah, Vijay Ganji |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/14/1/24 |
Similar Items
-
COVID-19 related to sarcopenia: Current perspectives on etiology, clinical implications, and nutritional rehabilitation
by: Elis Regina Muller Ramos, et al.
Published: (2023-09-01) -
Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus
by: Fuyuko Takahashi, et al.
Published: (2021-11-01) -
Sarcopenia is a Frequent Disease in Sars-Cov-2 Infection
by: Sandro Iannaccone, et al.
Published: (2023-01-01) -
Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
by: Li Huang, et al.
Published: (2021-08-01) -
Effects of physical activity on the severity of illness and mortality in COVID-19 patients: A systematic review and meta-analysis
by: Nuttawut Sittichai, et al.
Published: (2022-11-01)